Ionis Pharmaceuticals IONS Increase (Decrease) in Other Operating Assets
Increase (Decrease) in Other Operating Assets at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's increase (decrease) in other operating assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's increase (decrease) in other operating assets?
- Ionis Pharmaceuticals (IONS) reported increase (decrease) in other operating assets of $7.39M in Q1 2026.
- How has Ionis Pharmaceuticals's increase (decrease) in other operating assets changed year-over-year?
- Ionis Pharmaceuticals's increase (decrease) in other operating assets decreased by 40.2% year-over-year, from $12.37M to $7.39M.
- What is the long-term trend for Ionis Pharmaceuticals's increase (decrease) in other operating assets?
- Over 2 years (2021 to 2024), Ionis Pharmaceuticals's increase (decrease) in other operating assets has grown at a 455.7% compound annual growth rate (CAGR), from $877K to $27.08M.
- What does increase (decrease) in other operating assets mean?
- The net change in miscellaneous short-term assets used for daily operations.
- How do you interpret increase (decrease) in other operating assets?
- Large fluctuations may indicate changes in prepaid expenses or other operational commitments that impact short-term cash flow.
- How does increase (decrease) in other operating assets compare across companies?
- Standard working capital line item found in most corporate cash flow statements.